| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 06/22/2006 | US20060135516 3-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors |
| 06/22/2006 | US20060135488 protein tyrosine phosphatase 1B (PTP1B) modulators; type 2 diabetes, obesity; increasing insulin sensitivity; 1-Carboxymethoxy-3,8-dithia-cyclopenta[a]indene-2-carboxylic acid |
| 06/22/2006 | CA2591430A1 Nicotinic acetylcholine receptor ligands |
| 06/22/2006 | CA2591079A1 Bridged ring nk1 antagonists |
| 06/22/2006 | CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/21/2006 | EP1671943A1 Preparation of EKB-569 and related intermediates |
| 06/21/2006 | EP1670840A1 Process for making amide acetals |
| 06/21/2006 | EP1670793A1 Antibacterial agents |
| 06/21/2006 | EP1670783A2 Antithrombotic aromatic ethers |
| 06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | CN1791576A Benzamide modulators of metabotropic glutamate receptors |
| 06/21/2006 | CN1789267A Method for synthesizing tricyclic compound |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/20/2006 | US7064131 Compounds and methods for inhibiting MRP1 |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064122 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 06/15/2006 | WO2006061417A2 Macrocyclic quinazole derivatives and their use as mtki |
| 06/15/2006 | WO2006061415A1 2,4 (4,6) pyrimidine derivatives |
| 06/15/2006 | WO2006060919A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 06/15/2006 | WO2005117986A3 Antibody drug conjugates and methods |
| 06/15/2006 | US20060128774 Coatings for automotive and architectural structures;coatings cure rapidly with low VOC emissions |
| 06/15/2006 | US20060128741 Such as N,8-Dimethyl-2-(methylthio)-8H-imidazo[4,5-d]thiazolo[4,5-b]pvridin-5-amine; inflammatory and immune diseases; i-kappa-b kinase inhibitors |
| 06/15/2006 | US20060128713 (6-Chloro-3,4-dihydro-1H-benzo[4,5]thieno[2,3-c]pyridin-2-yl)-(2-isopropoxy-5-methanesulfonyl-phenyl)-methanone; glyicne transporter 1 (GlyT-1) and N-methyl-D-aspartate (NMDA) receptors inhibitor; psychoses, schizophrenia, attention deficit disorders, Alzheimer's disease; cognition activator |
| 06/15/2006 | US20060128711 derivatives of ecteinascidins, particularly ecteinascidin 736, used for the treatment of lung, colon, kidney, prostate, cervical, ovarian, breast or pancreatic cancer, leukaemia or melanoma in mammals; reduced systemic toxicity and improved pharmacokinetics |
| 06/15/2006 | US20060128697 Disease associated with AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) flux; cognitive disorders, anxiety or depressive syndromes, neurodegenerative diseases; N-(2-{4-[(5,5-dioxido-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazin-7-yl)oxy]phenyl}ethyl)methanesulphonamide |
| 06/15/2006 | US20060128687 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/15/2006 | CA2588764A1 Macrocyclic quinazole derivatives and their use as mtki |
| 06/15/2006 | CA2588761A1 2,4(4,6)pyrimidine derivatives |
| 06/15/2006 | CA2587508A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 06/14/2006 | EP1668012A1 Method for preparing cucurbiturils |
| 06/14/2006 | EP1667995A1 Benzimidazole acetonitriles |
| 06/14/2006 | EP1476136B1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation |
| 06/14/2006 | CN1788005A Novel phenoxazinone derivatives as enzyme substrates and use thereof as indicator in the detection of microorganisms with peptidase activity |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/13/2006 | US7060831 Process for the preparation of tetrahydrothieno[3,2-c] pyridine derivatives |
| 06/13/2006 | US7060828 Angiogenosis inhibitor; anticancer agents |
| 06/13/2006 | US7060821 Osteoclast differentiation inhibitors |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives |
| 06/08/2006 | WO2006060737A2 Mitotic kinesin inhibitors |
| 06/08/2006 | WO2006060617A1 Ascomycin crystalline forms and preparation thereof |
| 06/08/2006 | WO2006060616A1 Processes for producing crystalline macrolides |
| 06/08/2006 | WO2006060615A1 Non-hygroscopic and powdery amorphous pimecrolimus |
| 06/08/2006 | WO2006060614A1 Methods for preparing pimecrolimus |
| 06/08/2006 | WO2006059103A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 06/08/2006 | US20060122178 Compounds having activity as inhibitors of apoptosis |
| 06/08/2006 | US20060122167 C6-and c9-substituted isoxazoline derivatives and their use as anti-depressants |
| 06/08/2006 | US20060121551 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indicator in the detection of microorganisms with peptidase activity |
| 06/08/2006 | US20060121503 Chemically reactive carbocyanine dyes that are intramolecularly connected or crosslinked between the 1-position and 3'-position by a polyamino acid linker; reduction of the ground state aggregation caused by steric hindrance of the crosslinking results in more fluorescent on proteins and nucleic acids |
| 06/08/2006 | CA2584430A1 Methods for preparing pimecrolimus |
| 06/08/2006 | CA2584365A1 Ascomycin crystalline forms and preparation thereof |
| 06/08/2006 | CA2584360A1 Processes for producing crystalline macrolides |
| 06/08/2006 | CA2584358A1 Non-hygroscopic and powdery amorphous pimecrolimus |
| 06/07/2006 | EP1664062A1 Isothiazoloquinolones and related compounds as anti-infective agents |
| 06/07/2006 | EP1664061A1 Process for the synthesis of morphinane compounds and intermediates thereof |
| 06/07/2006 | EP1664060A1 Method for the manufacture of thip |
| 06/07/2006 | EP1664058A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 06/07/2006 | EP1664038A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved i in vivo /i efficacy |
| 06/07/2006 | EP1663999A2 Inhibitors of phosphodiesterase type-iv |
| 06/07/2006 | EP1663237A2 Fused ring heterocycles as potassium channel modulators |
| 06/07/2006 | EP1663227A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 06/07/2006 | EP1663107A2 Rifamycin analogs and uses thereof |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | CN1784402A Imidazo and thiazolopyridines as JAK3 kinase inhibitors |
| 06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
| 06/07/2006 | CN1781921A Compounds for treating impaired fundic relaxation |
| 06/07/2006 | CN1258533C Antihistaminic spiro compounds |
| 06/07/2006 | CN1258531C Aminomethyl pyrrolidine derivatives having aromatic substituents |
| 06/06/2006 | US7057046 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/06/2006 | US7057045 oxidation with potassium permanganate to cleave oxazolidinedione ring in methanol solvent, and reacting with potassium t-butoxide in dimethylformamide to deblock; testosterone-5 alpha -reductase inhibitors, for treatment of hyperandrogenic disorders |
| 06/06/2006 | US7057042 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 06/06/2006 | US7056908 Containing indolecarbazole compounds, such as staurosporine. |
| 06/06/2006 | US7056490 with neutral framework containing germanium and at least one tetravalent element other than germanium, preferably silicon, and optionally fluorine, prepared in the presence of an organonitrogen compound; absence of compensating cations makes available pore volume higher, advantageous for use as adsorbent |
| 06/06/2006 | CA2362632C R-substituted-2- or 3-aminomethyl-4-amino-3,4-dihydro-2h-1,4-benzoxazines as intermediates for producing analgesic agents |
| 06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2006056600A1 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity |
| 06/01/2006 | WO2006035310A3 Process for preparing bicyclic pyrazolyl compounds |
| 06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116513 such as 11-(2-dimethylamino-ethyl)-6,11-dihydro-5-thia-11-aza-benzo[a]fluoren-8-ol and 11-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-6,11-dihydro-5-thia-11-aza-benzo [a]fluoren-8-ol; selective estrogen and androgen receptor modulators |
| 06/01/2006 | US20060116512 3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-sulfonic acid {3-[(R)-5-(6-methoxy-quinolin-4-yl)-2-oxo-oxazolidin-3-yl]-propyl}-amide; to treat bacterial infections specially drug resistant |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116378 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 06/01/2006 | US20060115879 Process for producing anticancer agent LL-D45042 |
| 06/01/2006 | US20060115871 Protein interaction reporter agents and methods for using same |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 06/01/2006 | CA2585857A1 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity |
| 05/31/2006 | EP1661899A1 Organic electroluminescent device |
| 05/31/2006 | EP1661898A1 Bicyclic piperazine compound and use thereof |
| 05/31/2006 | EP1661890A1 Ppar-activating compound and pharmaceutical composition containing same |
| 05/31/2006 | EP1660497A1 [ 1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 05/31/2006 | EP1660458A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 05/31/2006 | EP1660090A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 05/31/2006 | EP1660081A1 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and pharmaceutical compositions containing the same |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |